Provided by Tiger Trade Technology Pte. Ltd.

Oragenics

0.6565
+0.01151.78%
Post-market: 0.6450-0.0115-1.75%19:20 EST
Volume:22.23K
Turnover:14.50K
Market Cap:2.74M
PE:-0.25
High:0.6600
Open:0.6500
Low:0.6423
Close:0.6450
52wk High:9.60
52wk Low:0.6111
Shares:4.17M
Float Shares:4.03M
Volume Ratio:0.25
T/O Rate:0.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.6420
EPS(LYR):-47.8817
ROE:-168.95%
ROA:-71.33%
PB:0.28
PE(LYR):-0.01

Loading ...

Oragenics Receives Regulatory and Ethics Approvals for Phase 2 Clinical Trial of ONP-002 in Australia

Reuters
·
Feb 09

Oragenics Targets Projected $9 Billion Market by Advancing First and Only Clinical-Stage Concussion and Mild Traumatic Brain Injury Therapy

GlobeNewswire
·
Feb 09

Oragenics partners with Duck Flats Pharma to support FDA IND trial design

TIPRANKS
·
Feb 03

Oragenics Inc. kooperiert mit DUCK FLATS Pharma zur Entwicklung einer intranasalen Therapie gegen Gehirnerschütterungen

Reuters
·
Feb 03

Oragenics Partners With Duck Flats Pharma to Support FDA Ind Readiness and Clinical Trial Design for Concussion Program

THOMSON REUTERS
·
Feb 03

Oragenics Showcases Concussion Therapeutic at SCOPE Summit

Reuters
·
Feb 02

Oragenics Extends At-the-Market Equity Sales Agreement

TIPRANKS
·
Jan 23

Oragenics files $100M mixed securities shelf

TIPRANKS
·
Jan 23

Oragenics Inc : Files for Mixed Shelf Offering of up to $100 Mln- SEC Filing

THOMSON REUTERS
·
Jan 23

Sabby Management, Llc Reports 9.9% Passive Stake in Oragenics as of Dec 31, 2025 - SEC Filing

THOMSON REUTERS
·
Jan 21

Oragenics to Present at the 2026 Sequire Investor Summit in Puerto Rico

GlobeNewswire
·
Jan 14

Oragenics Director Fred Telling Reports Sale of Common Shares

Reuters
·
Dec 16, 2025

Oragenics Raises CEO Salary, Awards Stock Options to Executives and Directors

Reuters
·
Dec 16, 2025

Reported November 7, 2025: Oragenics Q3 EPS $(1.96) Up From $(11.32) YoY

Benzinga
·
Nov 12, 2025

Oragenics Regains Full Nyse American Compliance, Company Resolves Stockholder Equity Deficiency

THOMSON REUTERS
·
Oct 21, 2025

BRIEF-Oragenics Enters Settlement Agreement With Ladenburg Thalmann - Sec Filing

Reuters
·
Oct 21, 2025

Oragenics Inc - Enters Settlement Agreement With Ladenburg Thalmann - SEC Filing

THOMSON REUTERS
·
Oct 21, 2025

Oragenics Inc - 8-K

THOMSON REUTERS
·
Oct 21, 2025

Oragenics, Receptor.AI partner to accelerate pipeline development

TIPRANKS
·
Oct 07, 2025

BRIEF-Oragenics Announces Strategic Partnership With Receptor.AI To Accelerate Pipeline Development

Reuters
·
Oct 07, 2025